Purpose: The consumption of vitamin/mineral supplements (VMS) and vitamin/mineral and/or dietary supplements (VMDS) is popular among the general population. However, the association of VMS/VMDS with fatigue remains sparse and conclusions are mixed. We aimed to understand the association between VMS/VMDS and fatigue.
Methods: Prospective study in the city of Lausanne, Switzerland, including 1361 participants (50.3% female, mean age 61.0 ± 9.4 years). Participants were divided into VMS/VMDS users and non-users. Fatigue levels were assessed using the Fatigue Severity Scale (FSS) and the 14-item version of the Chalder Fatigue Scale (CFS). Statistical analyses included multivariable logistic regression for categorical outcomes and analysis of variance for continuous outcomes, adjusting for relevant covariates.
Results: No association was found between VMS consumption and changes in FSS (mean ± standard error 0.05 ± 0.03 vs. -0.06 ± 0.14 for non-consumers and consumers, respectively, p = 0.440) and CFS (-0.05 ± 0.06 vs. 0.22 ± 0.28, p = 0.388). Similarly, no effect of VMS consumption was found on incidence odds ratio and 95% confidence interval: 1.75 (0.82-3.74), p = 0.149 or remission 1.36 (0.49-3.74), p = 0.550 of clinical fatigue. Similar findings were obtained for VMDS: FSS 0.06 ± 0.04 vs. 0 ± 0.08, p = 0.577; CFS - 0.07 ± 0.08 vs. 0.04 ± 0.15, p = 0.545 for non-consumers and consumers, respectively. OR 1.96 (1.20-3.20), p = 0.008 and 1.14 (0.57-2.31), p = 0.712 for incidence and remission of fatigue. Alternate or persistent VMS/ VMDS consumers had a higher incidence of clinical fatigue and a higher increase in FSS compared with never consumers.
Conclusion: In this population-based sample, we found no consistent association between VMS or VMDS consumption and remission of fatigue. Conversely, VMDS users tended to develop greater fatigue.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11889016 | PMC |
http://dx.doi.org/10.1007/s00394-025-03615-y | DOI Listing |
Curr Med Res Opin
March 2025
Merck Healthcare KGaA, Darmstadt, Germany.
Hypothyroidism is a relatively common condition that may affect as many as 10% of the population worldwide when its overt and subclinical presentations are considered. Important clinical comorbidities are highly prevalent in people with hypothyroidism and diminish quality of life and functional status in a manner that is proportional to the number of comorbidities present and their severity. This article reviews the common comorbidities of hypothyroidism, as reported in the literature.
View Article and Find Full Text PDFIndian J Otolaryngol Head Neck Surg
January 2025
Department of Endocrinology, Joshi Clinic, Mumbai, India.
Allergen immunotherapy (AIT), or specific immunotherapy (SIT), is an effective treatment for inducing immune tolerance to specific allergens. It is widely used for allergic rhinitis, conjunctivitis, asthma, and Hymenoptera venom allergies, with recent applications to food allergies and atopic dermatitis. Despite its benefits, the use of SIT in patients with autoimmune diseases is controversial due to concerns about its potential to induce or exacerbate autoimmune conditions.
View Article and Find Full Text PDFFront Pharmacol
February 2025
The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.
Introduction: Modern medical treatment of insomnia is often associated with issues like addiction, drug resistance, and a high risk of relapse post drug withdrawal. To tackle these challenges, the Chinese medicine formula Shuhe granule (SHG) has been employed in insomnia treatment at Guangdong Provincial Hospital of Chinese Medicine. Despite this, there is currently a lack of reliable evidence from evidence-based trials to support the widespread use of SHG in insomnia treatment.
View Article and Find Full Text PDFFront Neurol
February 2025
Department of Neurology, Affiliated Nanjing Brain Hospital, Nanjing Medical University, Nanjing, China.
Background: Varicella-zoster virus (VZV) central nervous system infection is typically observed in immunocompromised patients, and there is a lack of studies involving large samples of non-immunocompromised individuals. In this study, we retrospectively analyzed 108 non-immunocompromised patients diagnosed with VZV central nervous system infection.
Methods: This retrospective study was conducted in the Department of Neurology, Affiliated Nanjing Brain Hospital, Nanjing Medical University, China.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!